Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 21

1.

Platelet decoys inhibit thrombosis and prevent metastatic tumor formation in preclinical models.

Papa AL, Jiang A, Korin N, Chen MB, Langan ET, Waterhouse A, Nash E, Caroff J, Graveline A, Vernet A, Mammoto A, Mammoto T, Jain A, Kamm RD, Gounis MJ, Ingber DE.

Sci Transl Med. 2019 Feb 13;11(479). pii: eaau5898. doi: 10.1126/scitranslmed.aau5898.

PMID:
30760580
2.

Developmental barcoding of whole mouse via homing CRISPR.

Kalhor R, Kalhor K, Mejia L, Leeper K, Graveline A, Mali P, Church GM.

Science. 2018 Aug 31;361(6405). pii: eaat9804. doi: 10.1126/science.aat9804. Epub 2018 Aug 9.

3.

A facile approach to enhance antigen response for personalized cancer vaccination.

Li AW, Sobral MC, Badrinath S, Choi Y, Graveline A, Stafford AG, Weaver JC, Dellacherie MO, Shih TY, Ali OA, Kim J, Wucherpfennig KW, Mooney DJ.

Nat Mater. 2018 Jun;17(6):528-534. doi: 10.1038/s41563-018-0028-2. Epub 2018 Mar 5.

4.

Liposomal Delivery Enhances Immune Activation by STING Agonists for Cancer Immunotherapy.

Koshy ST, Cheung AS, Gu L, Graveline AR, Mooney DJ.

Adv Biosyst. 2017 Feb;1(1-2). pii: 1600013. doi: 10.1002/adbi.201600013. Epub 2017 Jan 5.

5.

A Broad-Spectrum Infection Diagnostic that Detects Pathogen-Associated Molecular Patterns (PAMPs) in Whole Blood.

Cartwright M, Rottman M, Shapiro NI, Seiler B, Lombardo P, Gamini N, Tomolonis J, Watters AL, Waterhouse A, Leslie D, Bolgen D, Graveline A, Kang JH, Didar T, Dimitrakakis N, Cartwright D, Super M, Ingber DE.

EBioMedicine. 2016 Jul;9:217-227. doi: 10.1016/j.ebiom.2016.06.014. Epub 2016 Jun 13.

6.

A shear gradient-activated microfluidic device for automated monitoring of whole blood haemostasis and platelet function.

Jain A, Graveline A, Waterhouse A, Vernet A, Flaumenhaft R, Ingber DE.

Nat Commun. 2016 Jan 6;7:10176. doi: 10.1038/ncomms10176.

7.

Improved treatment of systemic blood infections using antibiotics with extracorporeal opsonin hemoadsorption.

Didar TF, Cartwright MJ, Rottman M, Graveline AR, Gamini N, Watters AL, Leslie DC, Mammoto T, Rodas MJ, Kang JH, Waterhouse A, Seiler BT, Lombardo P, Qendro EI, Super M, Ingber DE.

Biomaterials. 2015 Oct;67:382-92. doi: 10.1016/j.biomaterials.2015.07.046. Epub 2015 Jul 26.

PMID:
26253638
8.

An extracorporeal blood-cleansing device for sepsis therapy.

Kang JH, Super M, Yung CW, Cooper RM, Domansky K, Graveline AR, Mammoto T, Berthet JB, Tobin H, Cartwright MJ, Watters AL, Rottman M, Waterhouse A, Mammoto A, Gamini N, Rodas MJ, Kole A, Jiang A, Valentin TM, Diaz A, Takahashi K, Ingber DE.

Nat Med. 2014 Oct;20(10):1211-6. doi: 10.1038/nm.3640. Epub 2014 Sep 14.

PMID:
25216635
9.

IL-27 increases BST-2 expression in human monocytes and T cells independently of type I IFN.

Guzzo C, Jung M, Graveline A, Banfield BW, Gee K.

Sci Rep. 2012;2:974. doi: 10.1038/srep00974. Epub 2012 Dec 13.

10.

Nitric oxide regulates pulmonary vascular smooth muscle cell expression of the inducible cAMP early repressor gene.

Steinbicker AU, Liu H, Jiramongkolchai K, Malhotra R, Choe EY, Busch CJ, Graveline AR, Kao SM, Nagasaka Y, Ichinose F, Buys ES, Brouckaert P, Zapol WM, Bloch KD.

Nitric Oxide. 2011 Oct 30;25(3):294-302. doi: 10.1016/j.niox.2011.05.006. Epub 2011 May 27.

11.

Phosphodiesterase 3A expression is modulated by nitric oxide in rat pulmonary artery smooth muscle cells.

Busch CJ, Graveline AR, Jiramongkolchai K, Liu H, Sanchez LS, Bloch KD.

J Physiol Pharmacol. 2010 Dec;61(6):663-9.

12.

Inhaled agonists of soluble guanylate cyclase induce selective pulmonary vasodilation.

Evgenov OV, Kohane DS, Bloch KD, Stasch JP, Volpato GP, Bellas E, Evgenov NV, Buys ES, Gnoth MJ, Graveline AR, Liu R, Hess DR, Langer R, Zapol WM.

Am J Respir Crit Care Med. 2007 Dec 1;176(11):1138-45. Epub 2007 Sep 13.

13.

Congenital NOS2 deficiency prevents impairment of hypoxic pulmonary vasoconstriction in murine ventilator-induced lung injury.

Liu R, Hotta Y, Graveline AR, Evgenov OV, Buys ES, Bloch KD, Ichinose F, Zapol WM.

Am J Physiol Lung Cell Mol Physiol. 2007 Nov;293(5):L1300-5. Epub 2007 Aug 24.

14.

Soluble guanylate cyclase-alpha1 deficiency selectively inhibits the pulmonary vasodilator response to nitric oxide and increases the pulmonary vascular remodeling response to chronic hypoxia.

Vermeersch P, Buys E, Pokreisz P, Marsboom G, Ichinose F, Sips P, Pellens M, Gillijns H, Swinnen M, Graveline A, Collen D, Dewerchin M, Brouckaert P, Bloch KD, Janssens S.

Circulation. 2007 Aug 21;116(8):936-43. Epub 2007 Aug 6.

PMID:
17679618
15.

Disruption of nitric oxide synthase 3 protects against the cardiac injury, dysfunction, and mortality induced by doxorubicin.

Neilan TG, Blake SL, Ichinose F, Raher MJ, Buys ES, Jassal DS, Furutani E, Perez-Sanz TM, Graveline A, Janssens SP, Picard MH, Scherrer-Crosbie M, Bloch KD.

Circulation. 2007 Jul 31;116(5):506-14. Epub 2007 Jul 16.

PMID:
17638931
16.

Cardiomyocyte-restricted restoration of nitric oxide synthase 3 attenuates left ventricular remodeling after chronic pressure overload.

Buys ES, Raher MJ, Blake SL, Neilan TG, Graveline AR, Passeri JJ, Llano M, Perez-Sanz TM, Ichinose F, Janssens S, Zapol WM, Picard MH, Bloch KD, Scherrer-Crosbie M.

Am J Physiol Heart Circ Physiol. 2007 Jul;293(1):H620-7. Epub 2007 Apr 6.

17.

Cardiomyocyte-specific overexpression of nitric oxide synthase 3 prevents myocardial dysfunction in murine models of septic shock.

Ichinose F, Buys ES, Neilan TG, Furutani EM, Morgan JG, Jassal DS, Graveline AR, Searles RJ, Lim CC, Kaneki M, Picard MH, Scherrer-Crosbie M, Janssens S, Liao R, Bloch KD.

Circ Res. 2007 Jan 5;100(1):130-9. Epub 2006 Nov 30.

PMID:
17138944
18.

MyD88 and NOS2 are essential for toll-like receptor 4-mediated survival effect in cardiomyocytes.

Zhu X, Zhao H, Graveline AR, Buys ES, Schmidt U, Bloch KD, Rosenzweig A, Chao W.

Am J Physiol Heart Circ Physiol. 2006 Oct;291(4):H1900-9. Epub 2006 Apr 28.

19.

Nitric oxide induces phosphodiesterase 4B expression in rat pulmonary artery smooth muscle cells.

Busch CJ, Liu H, Graveline AR, Bloch KD.

Am J Physiol Lung Cell Mol Physiol. 2006 Apr;290(4):L747-L753. Epub 2005 Nov 18.

20.

[Antireticulo-endothelial cytotoxic therapy; Bogomoletz serum].

GRAVELINE A.

Clin Nuova Rass Prog Med Int. 1952 Nov 22;15(21-23):436-7. No abstract available.

PMID:
13107002
21.

Les antiallergiques de synth├Ęse et l'allergie.

GRAVELINE A.

Ars Med Rev Int Med Prat. 1948 May 15;3(5):325-97. Undetermined Language. No abstract available.

PMID:
18864151

Supplemental Content

Loading ...
Support Center